Status:
UNKNOWN
Research on Endoscopic Precision Biopsy.
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Colorectal Adenoma
Eligibility:
All Genders
30-75 years
Brief Summary
Colorectal adenoma is a common disease and frequently-occurring disease in gastroenterology. With the continuous progress of colonoscopy equipment and the gradual improvement of endoscopic accessories...
Eligibility Criteria
Inclusion
- Age between 30-75;
- Those who have no mental abnormality and can conduct questionnaire surveys;
- BBPS ≥ 6;
- Colorectal advanced adenoma, and admitted for complete resection with EMR and ESD;
- Provide the relevant information required by this study and sign the informed consent.
Exclusion
- Those who cannot provide the relevant information required by this research;
- Patients with inflammatory bowel disease;
- Those with a history of liver cirrhosis, uncontrolled hypertension, history of myocardial infarction, cardiac insufficiency, renal insufficiency, respiratory failure, diabetic ketosis and electrolyte imbalance and other serious diseases;
- Those who cannot stop antiplatelet drugs or anticoagulant drugs;
- Those who have not completed full colonoscopy;
- Pregnant women.
Key Trial Info
Start Date :
November 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05261932
Start Date
November 26 2021
End Date
November 30 2023
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, China, 102218